{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,10]],"date-time":"2025-10-10T01:56:33Z","timestamp":1760061393136},"reference-count":0,"publisher":"Georg Thieme Verlag KG","issue":"2","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Pharmacopsychiatry"],"published-print":{"date-parts":[[2004,3]]},"DOI":"10.1055\/s-2004-815528","type":"journal-article","created":{"date-parts":[[2004,3,29]],"date-time":"2004-03-29T13:12:32Z","timestamp":1080565952000},"page":"69-73","source":"Crossref","is-referenced-by-count":14,"title":["Relationship between Haloperidol Plasma Concentration, Debrisoquine Metabolic Ratio,<i>CYP2D6<\/i>and<i>CYP2C9<\/i>Genotypes in Psychiatric Patients"],"prefix":"10.1055","volume":"37","member":"194","container-title":["Pharmacopsychiatry"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.thieme-connect.de\/products\/ejournals\/pdf\/10.1055\/s-2004-815528.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2017,5,22]],"date-time":"2017-05-22T19:34:19Z","timestamp":1495481659000},"score":1,"resource":{"primary":{"URL":"http:\/\/www.thieme-connect.de\/DOI\/DOI?10.1055\/s-2004-815528"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2004,3]]},"references-count":0,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2004,3]]}},"URL":"https:\/\/doi.org\/10.1055\/s-2004-815528","relation":{},"ISSN":["0176-3679","1439-0795"],"issn-type":[{"value":"0176-3679","type":"print"},{"value":"1439-0795","type":"electronic"}],"subject":[],"published":{"date-parts":[[2004,3]]}}}